Moderna test results still leave questions: STAT News
The markets take a hit after STAT News raises questions about Moderna vaccine test results. With CNBC's Melissa Lee and the Fast Money traders, Guy Adami, Tim Seymour, Steve Grasso and Karen Finerman.
Heavy hearts soared Monday with news that Moderna’s Covid-19 vaccine candidate — the frontrunner in the American market — seemed to be generating an immune response in Phase 1 trial subjects. The company’s stock valuation also surged, hitting $29 billion, an astonishing feat for a company that currently sells zero products.
But was there good reason for so much enthusiasm? Several vaccine experts asked by STAT concluded that, based on the information made available by the Cambridge, Mass.-based company, there’s really no way to know how impressive — or not — the vaccine may be.
While Moderna blitzed the media, it revealed very little information — and most of what it did disclose were words, not data. That’s important: If you ask scientists to read a journal article, they will scour data tables, not corporate statements. With science, numbers speak much louder than words.
Even the figures the company did release don’t mean much on their own, because critical information — effectively the key to interpreting them — was withheld.
Experts suggest we ought to take the early readout with a big grain of salt. Here are a few reasons why.
For access to live and exclusive video from CNBC subscribe to CNBC PRO:
https://cnb.cx/2JdMwO7
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
#CNBC
#CNBC TV
Видео Moderna test results still leave questions: STAT News канала CNBC Television
Heavy hearts soared Monday with news that Moderna’s Covid-19 vaccine candidate — the frontrunner in the American market — seemed to be generating an immune response in Phase 1 trial subjects. The company’s stock valuation also surged, hitting $29 billion, an astonishing feat for a company that currently sells zero products.
But was there good reason for so much enthusiasm? Several vaccine experts asked by STAT concluded that, based on the information made available by the Cambridge, Mass.-based company, there’s really no way to know how impressive — or not — the vaccine may be.
While Moderna blitzed the media, it revealed very little information — and most of what it did disclose were words, not data. That’s important: If you ask scientists to read a journal article, they will scour data tables, not corporate statements. With science, numbers speak much louder than words.
Even the figures the company did release don’t mean much on their own, because critical information — effectively the key to interpreting them — was withheld.
Experts suggest we ought to take the early readout with a big grain of salt. Here are a few reasons why.
For access to live and exclusive video from CNBC subscribe to CNBC PRO:
https://cnb.cx/2JdMwO7
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
#CNBC
#CNBC TV
Видео Moderna test results still leave questions: STAT News канала CNBC Television
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
![Markets close out worst week since the pandemic](https://i.ytimg.com/vi/RC_ke1dLxto/default.jpg)
![What's Next For The U.S. Economy: Mohamed El-Erian](https://i.ytimg.com/vi/LVE4gwl5wjU/default.jpg)
![Job stats are bright and will keep the economy going, says Cerity's Jim Lebenthal](https://i.ytimg.com/vi/uqZSlrok2JU/default.jpg)
![India-China clash: 20 Indian troops killed in Ladakh fighting - BBC News](https://i.ytimg.com/vi/2Y4joh_ebqM/default.jpg)
![Will Trump take responsibility if rallygoers get sick? Hear McEnany's answer](https://i.ytimg.com/vi/8LKm76D-Rf0/default.jpg)
![Consumers Keep Spending, But for How Long?: Naftali Holtz & Richard McPhail at CNBC FA Summit](https://i.ytimg.com/vi/BkSsPAJf94c/default.jpg)
![Jim Cramer: The lesson from Wall Street's biggest sell-off since March](https://i.ytimg.com/vi/OWDgzmaLAwo/default.jpg)
![Former FDA chief on Moderna's early-stage vaccine trial results](https://i.ytimg.com/vi/d78GjUcJFk4/default.jpg)
![Market may bottom toward the end of June, says Fundstrat's Mark Newton](https://i.ytimg.com/vi/BpmXC-sd4_w/default.jpg)
![Cramer's game plan for the trading week of June 20](https://i.ytimg.com/vi/X0vQHSwnGaA/default.jpg)
![20 Indian soldiers killed in border clashes with Chinese forces | DW News](https://i.ytimg.com/vi/xI1qztu0KIY/default.jpg)
![There's signs the economy is weakening, says BD8 Capital's Barbara Doran](https://i.ytimg.com/vi/kLuGznqkx9I/default.jpg)
![Multiples need to be undervalued to get a good bottom, says Requisite's Bryn Talkington](https://i.ytimg.com/vi/GukbDeZF2cc/default.jpg)
![The market needs to see oil and gas come down, says Solus' Dan Greenhaus](https://i.ytimg.com/vi/w6urhh6CkRk/default.jpg)
![Another heat wave to hit country this weekend](https://i.ytimg.com/vi/AbKdlUBMXDs/default.jpg)
![Nikola executive chairman on the EV truck maker's electric surge](https://i.ytimg.com/vi/ZNuiqM6vg9A/default.jpg)
![Two-minute drill: ET](https://i.ytimg.com/vi/ttR-SON4JoQ/default.jpg)
![Jim Grant on the market's response to the Fed's economic outlook](https://i.ytimg.com/vi/FehkQ9jE_FQ/default.jpg)
![Coronavirus: Moderna CEO on the promising preliminary results of early-stage study](https://i.ytimg.com/vi/t-zwecJ9qxk/default.jpg)
![Qualcomm CEO discusses the impact of Covid lockdowns in China on business](https://i.ytimg.com/vi/NpoYRh5p-Mo/default.jpg)